SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending due to Nvidia's latest filing revealing an exit from its APLD position, sparking panic selling and concerns about investor confidence. However, many in the community contend this is old news from Q4 2025 and a strategic move by Nvidia, arguing APLD's strong data center fundamentals and upcoming hyperscaler contracts remain intact.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is actively discussed amidst market concern that AI advancements could disrupt enterprise software, yet a strong community sentiment highlights the stock's deep value, robust cash flow, and strategic AI integration as reasons for optimism against an overblown "AI apocalypse" narrative.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is trending after the FDA extended the PDUFA date for its dry eye drug, Reproxalap, to March 2026, requesting additional data but having already shared a draft label and raising no new issues. This has split community sentiment between those who see it as a positive sign of likely approval, citing AbbVie's pre-launch activities, and others who remain wary due to prior rejections and a recent executive departure.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending after its latest earnings, which saw a beat on current quarter figures but a lowered profit outlook for upcoming periods, despite increased revenue guidance. This mixed report has sparked a sharp debate among investors, with some viewing the significant sell-off as an overreaction driven by broader software sector fears about AI, while others point to high valuations and M&A integration costs as justified concerns.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion Inc. is trending following its public debut on the NYSE and upcoming opening bell ceremony, with the community enthusiastically touting its differentiated neutral-atom quantum technology and existing commercialized products. Investors are highlighting its major government and industry partnerships, viewing it as an undervalued leader poised for significant growth in the burgeoning quantum sector.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

CMPS is experiencing a significant surge following highly positive Phase 3 trial results for its COMP360 psilocybin therapy in treatment-resistant depression, with the company accelerating commercialization plans and seeking a rolling FDA submission. The community is actively debating the stock's long-term potential as a pioneer in psychedelic treatments, though a proposed public offering is generating concerns about dilution and short-term volatility.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow With Knife ($CAW) is gaining traction with its highly engaged community driving conversation around its multichain expansion to ecosystems like Solana and Base via Layerzero/Stargate, coupled with a deflationary burning mechanism and an emphasis on its fully organic, community-led project without hidden developer wallets.

Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual, and cloud environments. Its products and services include Myriad All-Flash File and Object, StorNext File System Unified Surveillance Platform, ActiveScale Object Storage, DXi Backup Appliances, Scalar Tape Storage, CatDV Media Asset Management, and Cloud-Based Analytics. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in Centennial, CO.

Quantum Corp

Quantum Corp. is trending following its latest earnings report which showed results exceeding expectations, with the CEO emphasizing benefits from a revitalized sales organization and increasing demand for AI-ready data infrastructure. Community discussions highlight the company's role in big data solutions for AI, while many clarify it is not a quantum computing stock despite its name.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera (ATOM) is trending with record trading volume following its Q4 2025 earnings call, where management expressed strong confidence in securing near-term licensing and commercial agreements for its Mears Silicon Technology in advanced Gate-All-Around (GAA) and AI chip applications. The community is actively discussing the potential for significant power efficiency improvements in semiconductors and a possible short squeeze, despite historical skepticism surrounding its pre-revenue status.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma Inc. is trending as its latest earnings call signals a definitive pivot towards commercialization of its disruptive III-V-on-silicon photonics technology, fueling community speculation about imminent Tier-1 customer design wins, especially for Apple's future SWIR sensors and energy-efficient AI data centers. Analysts have reiterated buy ratings, highlighting the company's unique market position and low float.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ANVS p-tau217 is a breakthrough blood test for risk of developing Alzheimer&#39;s disease. Important to know there are sex differences for this biomarker, with women having higher values at baseline and more tau deposition. @JAMANeuro 
http://jamanetwork.com/journals/jaman…

The p-tau217 breakthrough is a game-changer for ANVS, offering a low-cost, precise way to prove Buntanetap’s efficacy. Using this biomarker in the PDD study allows Maria to target high-risk patients—especially women—while providing the objective data the FDA requires. It transforms the trial into precision medicine, simplifies bridging data from the AD study, and creates a faster, more credible path to approval.

peter lawrence

Mikey

Kay Nein

Mihail yamamura

kgw567

Jamanetwork

StockTwits for iOS

Annovis Bio Inc

 p-tau217 is a breakthrough blood test for risk of developing Alzheimer's disease. Important to know there are sex differences for this biomarker, with women having higher values at baseline and more tau deposition. 

…

The p-tau217 breakthrough is a game-changer for ANVS, offering a low-cost, precise way to prove Buntanetap’s efficacy. Using this biomarker in the PDD study allows Maria to target high-risk patients—especially women—while providing the objective data the FDA requires. It transforms the trial into precision medicine, simplifies bridging data from the AD study, and creates a faster, more credible path to approval.

Mads Jorgensen

@Madsj79 @JAMANeuro There is no money to pay utility bill, PDD trial is a pipe dream at this point. This will delist in fall if keep falling below $50mil market cap.

john

StockTwits Web

 There is no money to pay utility bill, PDD trial is a pipe dream at this point. This will delist in fall if keep falling below $50mil market cap.